Title: Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time
Authors: Smith, Peter K ×
Carrier, Michel
Chen, John C
Haverich, Axel
Levy, Jerrold H
Menasche, Philippe
Shernan, Stanton K
Van de Werf, Frans
Adams, Peter X
Todaro, Thomas G
Verrier, Edward #
Issue Date: Sep-2006
Publisher: Elsevier Science
Series Title: Annals of Thoracic Surgery vol:82 issue:3 pages:781-789
Conference: 52nd Annual Meeting of the Southern-Thoracic-Surgical-Association location:Orlando date:10 - 12 Nov 2005
Abstract: Background. Prolonged cross-clamp time during cardiac surgery increases the risk of postoperative mortality and myocardial injury. This subanalysis from the pexelizumab for reduction of infarction and mortality in coronary artery bypass grafting surgery ( PRIMO-CABG) trial, a phase III double-blind, placebo-controlled study of 3,099 patients undergoing on-pump coronary artery bypass graft surgery with or without valve surgery, assessed the impact of pexelizumab, an investigational C5 complement inhibitor, on postoperative outcomes after prolonged aortic cross-clamp time.
ISSN: 0003-4975
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Cardiology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science